Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
Authors
Keywords
-
Journal
BLOOD
Volume 124, Issue 9, Pages 1513-1521
Publisher
American Society of Hematology
Online
2014-06-27
DOI
10.1182/blood-2014-03-560227
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profiling
- (2014) E. Taskesen et al. BLOOD
- Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
- (2013) L. Malcovati et al. BLOOD
- JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
- (2013) E. Rumi et al. BLOOD
- The genetic basis of myelodysplasia and its clinical relevance
- (2013) M. Cazzola et al. BLOOD
- Clonal architecture of chronic myelomonocytic leukemias
- (2013) R. Itzykson et al. BLOOD
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromes
- (2013) L. Senent et al. HAEMATOLOGICA
- SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
- (2012) M. Meggendorfer et al. BLOOD
- Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms
- (2012) M. Cazzola et al. BLOOD
- Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis
- (2012) J. Broseus et al. HAEMATOLOGICA
- High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms
- (2012) S. Jeromin et al. HAEMATOLOGICA
- Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers
- (2011) K. Naqvi et al. BLOOD
- Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
- (2011) L. Malcovati et al. BLOOD
- Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes
- (2011) Felicitas Thol et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
- (2011) Martin Jädersten et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
- (2011) E. Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
- (2010) S. T. Oh et al. BLOOD
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
- Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia
- (2010) Marc H. G. P. Raaijmakers et al. NATURE
- Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
- (2009) L. Malcovati et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Morphological evaluation of monocytes and their precursors
- (2009) J. E. Goasguen et al. HAEMATOLOGICA
- A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q– syndrome
- (2009) Jillian L Barlow et al. NATURE MEDICINE
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
- (2009) Daniel T Starczynowski et al. NATURE MEDICINE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts
- (2008) G. J. Mufti et al. HAEMATOLOGICA
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
- (2008) Benjamin L. Ebert et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started